Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1261-1269

  Tada, Motohisa ^a,b   Kanai, Fumihiko ^b   Tanaka, Yasuo ^a   Sanada, Masashi ^c   Nannya, Yasuhito ^c   Tateishi, Keisuke ^a   Ohta, Miki ^a   Asaoka, Yoshinari ^a   Seto, Motoko ^a   Imazeki, Fumio ^b   Yoshida, Haruhiko ^a   Ogawa, Seishi ^a   Yokosuka, Osamu ^b   Omata, Masao ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Yamanashi Prefectural Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER TISSUE; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; GENE LOCUS; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADULT; AGED; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; FEMALE; GENE DOSAGE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; STOMACH NEOPLASMS;

EID: 77953186827     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01500.x     Document Type: Article

References (44)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999, 83:18-29.
2. Peddanna N, Holt S, Verma RS. Genetics of gastric cancer. Anticancer Res 1995, 15:2055-64.
3. de Manzoni G, Tomezzoli A, Di Leo A, Moore PS, Talamini G, Scarpa A. Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer. Br J Surg 2001, 88:419-25.
4. Koo SH, Jeong TE, Kang J, Kwon KC, Park JW, Noh SM. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. Cancer Genet Cytogenet 2004, 153:26-31.
5. Inoue T, Uchino S, Shiraishi N, Adachi Y, Kitano S. Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis. Clin Cancer Res 1998, 4:973-7.
6. Weiss MM, Kuipers EJ, Postma C. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 2004, 26:307-17.
7. French AJ, Petroni G, Thibideau SN. Allelic imbalance of 8p indicates poor survival in gastric cancer. J Mol Diagn 2004, 6:243-52.
8. Hiyama T, Tanaka S, Yoshihara M. Chromosomal and microsatellite instability in sporadic gastric cancer. J Gastroenterol Hepatol 2004, 19:756-60.
9. Kallioniemi A, Kallioniemi OP, Sudar D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-21.
10. Zhao X, Li C, Paez JG. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 2004, 64:3060-71.
11. Bignell GR, Huang J, Greshock J. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res 2004, 14:287-95.
12. Kennedy GC, Matsuzaki H, Dong S. Large-scale genotyping of complex DNA. Nat Biotechnol 2003, 21:1233-7.
13. Nannya Y, Sanada M, Nakazaki K. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 2005, 65:6071-9.
14. Yamamoto G, Nannya Y, Kato M. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 2007, 81:114-26.
15. Wang TL, Maierhofer C, Speicher MR. Digital karyotyping. Proc Natl Acad Sci U S A 2002, 99:16156-61.
16. Luo L, Shen GQ, Stiffler KA, Wang QK, Pretlow TG, Pretlow TP. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 2006, 27:1153-9.
17. Lin JK, Chang SC, Yang YC, Li AF. Loss of heterozygosity and DNA aneuploidy in colorectal adenocarcinoma. Ann Surg Oncol 2003, 10:1086-94.
18. Takada H, Imoto I, Tsuda H. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005, 96:100-10.
19. Sakakura C, Mori T, Sakabe T. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999, 24:299-305.
20. Guan XY, Fu SB, Xia JC. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000, 123:27-34.
21. Tahara E. Molecular biology of gastric cancer. World J Surg 1995, 19:484-8. discussion 9-90
22. Douglas EJ, Fiegler H, Rowan A. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 2004, 64:4817-25.
23. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006, 7:85-97.
24. Redon R, Ishikawa S, Fitch KR. Global variation in copy number in the human genome. Nature 2006, 444:444-54.
25. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol 2002, 9:771-4.
26. Bonenkamp JJ, Hermans J, Sasako M. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999, 340:908-14.
27. Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol 2007, 46:277-85.
28. Aqeilan RI, Kuroki T, Pekarsky Y. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 2004, 10:3053-8.
29. Dumon KR, Ishii H, Fong LY. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci U S A 2001, 98:3346-51.
30. Smith DI, Zhu Y, McAvoy S, Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 2006, 232:48-57.
31. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994, 54:4481-7.
32. Zhao X, Weir BA, LaFramboise T. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 2005, 65:5561-70.
33. Wu CW, Kao HL, Li AF, Chi CW, Lin WC. Protein tyrosine-phosphatase expression profiling in gastric cancer tissues. Cancer Lett 2006, 242:95-103.
34. Wiedemeyer R, Westermann F, Wittke I, Nowock J, Schwab M. Ataxin-2 promotes apoptosis of human neuroblastoma cells. Oncogene 2003, 22:401-11.
35. Davison EJ, Tarpey PS, Fiegler H, Tomlinson IP, Carter NP. Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization. Genes Chromosomes Cancer 2005, 44:384-91.
36. Wang RA, Zhang H, Balasenthil S, Medina D, Kumar R. PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 2006, 25:2931-6.
37. Sanvito F, Vivoli F, Gambini S. Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer. Cancer Res 2000, 60:510-6.
38. Koontz JI, Soreng AL, Nucci M. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci U S A 2001, 98:6348-53.
39. Pennaneach V, Salles-Passador I, Munshi A. The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner. Mol Cell 2001, 7:715-27.
40. Snijders AM, Schmidt BL, Fridlyand J. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005, 24:4232-42.
41. Cui D, Jin G, Gao T. Characterization of BRCAA1 and its novel antigen epitope identification. Cancer Epidemiol Biomarkers Prev 2004, 13:1136-45.
42. Harada H, Kitagawa M, Tanaka N. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993, 259:971-4.
43. Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005, 11:5356-64.
44. Tonon G, Modi S, Wu L. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003, 33:208-13.